Aminosaccharides
Selleck Chemical LLC Apramycin Sulfate S4254-1g
Apramycin Sulfate (Ai3-29795) is an aminoglycoside antibiotic which binds to the deep groove of the RNA
Bioworld N-ACETYL-GALACTOSAMINE SEPA
N-ACETYL-GALACTOSAMINE SEPAROPORE (AGAROSE): N-acetyl-galactosamine Separopore n-acetyl-galactosamine is conjugated to Separopore.
Medchemexpress LLC D(+)-Galactosamine (hydrochloride) | 1772-03-8 | 99.9% | 215.63 | 200 MG
D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.
- Induces apoptosis and necrosis in primary cultures of rat hepatocytes.
- Induces caspase-3 activation and DNA fragmentation.
- Used to induce hepatitis models similar to viral hepatitis.
- Induces lipid peroxidation and deterioration of cell membranes.
- Can be used in rat models (Wistar) to study liver damage.
- Can be used in mouse models (C57BL/6J) for acute liver failure induction.
Medchemexpress LLC HY-B1125 100mg Medchemexpress, Glucosamine CAS:3416-24-8 Purity:>98%
Medchemexpress, HY-B1125 100mg Glucosamine CAS:3416-24-8 Glucosamine (D-Glucosamine) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride >=99% | 1772-03-8 | MFCD00135830 | 10MG
D-(+)-Galactosamine hydrochloride >=99% | Purity: >=99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 10MG
Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 25 MG
D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury through the generation of free radicals and depletion of UTP nucleotides. Intoxication with D(+)-Galactosamine hydrochloride also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. The combination of Lipopolysaccharide/D(+)-Galactosamine is a known animal model for inducing acute liver injury, leading to fulminant hepatic failure.
- Causes liver injury through generation of free radicals.
- Leads to depletion of UTP nucleotides.
- Induces renal dysfunction.
- Useful in animal models for acute liver injury.
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride | 1772-03-8 | MFCD00135830 | 5 g
D-(+)-Galactosamine hydrochloride | Purity: ≥99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 5 g
Sigma Aldrich Fine Chemicals Biosciences D-(+)-Galactosamine hydrochloride >=99% | 1772-03-8 | MFCD00135830 | 25G
D-(+)-Galactosamine hydrochloride >=99% | Purity: >=99% | Mol Wt: 215.63 | 1772-03-8 | MFCD00135830 | 25G
Medchemexpress LLC 2-azidoethyl β-D-lactoside | 230286-11-0 | MFCD19981033 | 95.0% | 411.36 g/mol | C14H25N3O11 | 10 MG
2-Azidoethyl β-D-lactoside is an azide-functionalized β-D-lactoside reagent designed for click-chemistry conjugation. It reacts with alkyne-containing molecules via copper-catalyzed azide-alkyne cycloaddition (CuAAC) or strain-promoted azide-alkyne cycloaddition (SPAAC), enabling efficient bioconjugation in glycochemistry and chemical biology workflows.
Sigma Aldrich Fine Chemicals Biosciences alpha D Glucosamine 1 phos25MG
alpha D Glucosamine 1 phos25MG
Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 100 MG
D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 100 MG
Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 1 G
D(+)-Galactosamine hydrochloride is an established experimental toxin known to primarily cause liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, often leading to renal failure associated with end-stage liver damage. This compound can be used to induce hepatitis models, mimicking viral hepatitis by causing lipid peroxidation and cell membrane deterioration.
- Induces apoptosis and necrosis in primary cultures of rat hepatocytes.
- Causes caspase-3 activation and DNA fragmentation.
- Used as an animal model for fulminant hepatic failure.
- Induces acute liver failure in mice when co-administered with Lipopolysaccharide.
Sigma Aldrich Fine Chemicals Biosciences 4-Methylumbelliferyl N-acetyl-beta-D-glucosaminide suitable for fluorescence, >=99.0% (TLC) | 37067-30-4 | MFCD00150977 | 250MG
4-Methylumbelliferyl N-acetyl-beta-D-glucosaminide suitable for fluorescence, >=99.0% (TLC) | Purity: >=99.0% (TLC) | Mol Wt: 379.36 | 37067-30-4 | MFCD00150977 | 250MG
Medchemexpress LLC D(+)-Galactosamine hydrochloride | 1772-03-8 | 99.9% | 215.63 | 500 MG
D(+)-Galactosamine hydrochloride is an established experimental toxin that primarily causes liver injury by generating free radicals and depleting UTP nucleotides. It also induces renal dysfunction, with renal failure often associated with the end-stage of liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.
- Induces apoptosis and necrosis in primary rat hepatocyte cultures.
- Causes caspase-3 activation and DNA fragmentation.
- Induces hepatotoxicity similar to viral hepatitis.
- Suitable for research use only.
Medchemexpress LLC Tak-418 hydrochloride | 1818252-53-7 | 99.8% | C17H25ClN2O2S | 10MG
TAK-418 is an orally active, CNS-penetrant inhibitor of lysine-specific demethylase 1 (LSD1/KDM1A) developed as a clinical candidate for neurodevelopmental and other central nervous system disorders. It is supplied as a research compound for in vitro and in vivo pharmacology, pharmacokinetics, and translational studies, with reported formula C17H25ClN2O2S and CAS 1818252-53-7.
- Selective LSD1 inhibition with reported low-nanomolar potency.
- Orally bioavailable and brain-penetrant for CNS studies.
- Suitable for in vitro and in vivo pharmacology.
- Available in small-mg research pack sizes for preclinical work.
- High reported purity for reproducible experimental results.
- Storage guidance supports long-term sample integrity.